Response to commentaries on ‘Alpha calculus in clinical trials: considerations for the new millennium’
✍ Scribed by Lemuel A. Moyé
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 47 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0277-6715
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Regardless of whether a statistician believes in letting a data set speak for itself through nominal p-values or believes in strict alpha conservation, the interpretation of experiments which are negative for the primary endpoint but positive for secondary endpoints is the source of some angst. The
The paper by Moyà e [1] provides useful discussion for some important statistical issues concerning the possibly complicated ways in which multiple comparisons across primary and secondary endpoints can a ect the results from clinical trials. How to balance tolerable in ation of type I error against